US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Personalized Medicine: market research reports

RSS Feeds

Personalized Medicine market research reports and industry analysis

  2    
Genetic Testing Market Outlook to 2017
5/1/2013 | published by: RNCOS
... 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to ...  |  read more...
$1,200.00
US Personalized Cancer Genome Sequencing Marketrncos
5/1/2013 | published by: RNCOS
... the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome ...  |  read more...
$1,200.00
Personalized Medicine Market Analysis
5/1/2013 | published by: RNCOS
... per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing ...  |  read more...
$1,200.00
Companion Diagnostics – Streamlining Drug Development and Advancing Personalized Medicine
4/1/2013 | published by: CBR Pharma Insights, LLC
... to gain ground. Companion diagnostics can be used in screening, monitoring, diagnosing and treating patients and can allow for stratification of patients to maximize efficacy and minimize risk Companion diagnostics can allow for a specific ...  |  read more...
$3,900.00
Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
1/18/2013 | published by: MarketsandMarkets
... potential opportunity in understanding the basis of various diseases in a different approach. Thus, epigenetics is study of heritable changes in genome function and gene expression had opened the new gate of biology to understand ...  |  read more...
$4,650.00
Cancer Peptides: From First-in-Class to Best-in-Class?
1/7/2013 | published by: BioSeeker Group AB
... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ...  |  read more...
$3,675.00
Breast Cancer Therapies Markets
11/1/2012 | published by: TriMark Publications
... such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. Breast Cancer Therapies Markets provides comprehensive information on major and minor shapers of the breast cancer drug treatment ...  |  read more...
$3,400.00
Personalized Medicine - A Global Market Overview
8/15/2012 | published by: Industry Experts
... factor, since everybody wants caregivers who can comprehend an individual’s problems. The day is not very far when this level of personal or individual understanding between a patient and a doctor would be much deeper ...  |  read more...
$3,600.00
Companion Diagnostics and Personalized Medicine Market Report 2012
8/1/2012 | published by: Select Biosciences Limited
... aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine. Companion Diagnostics has been rapidly expanding over the past 3 years and in this ...  |  read more...
$1,970.00
Case Study: Personalized Cancer Therapy - Anticipated competition threatens to dampen commercial potential of new approvals
7/16/2012 | published by: Datamonitor
... disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy. Scope In-depth analysis of companion diagnostic development – when to start ...  |  read more...
$1,900.00
The Impact of Health and Wellness on Products and Services
6/13/2012 | published by: Frost & Sullivan
... and openness and transparency - have been discussed. These four have been shortlisted among the others because greener products would have higher acceptance and increased demand, digitalization would be the key to reduce growing healthcare ...  |  read more...
$6,000.00
Molecular Diagnostics: Companion Diagnostics and Personalized Medicine
5/31/2012 | published by: Datamonitor
... so-called companion diagnostic, which typifies this movement. Features and benefits Full assessment of the market drivers and resistors for the personalized medicine movement. Detailed overview of the key pharmaceutical-diagnostic collaborative deals signed over the past ...  |  read more...
$1,900.00
Personalized Medicine: Companies, Trends and World Market
4/1/2012 | published by: Takeda Pacific
... report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Many people already know about DNA, genes and the ...  |  read more...
$2,495.00
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth
3/27/2012 | published by: GlobalData
... provides information and analysis on the global companion diagnostics market. The report provides information such as current trends and developments in the global companion diagnostics market (including recent deals and industry trends). The report also ...  |  read more...
$500.00
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
... the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara ...  |  read more...
$3,500.00
Companion Diagnostics in Personalized Medicine and Cancer Therapy
2/1/2012 | published by: TriMark Publications
... of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than ...  |  read more...
$3,400.00
Personalized Medicine for Cancer
9/30/2011 | published by: GlobalData
... The report also provides insights on the companion diagnostics and marketed personalized drugs for cancer. Scope The report provides information on the concept of personalized medicines, Challenges in development of personalized medicine and Benefits of ...  |  read more...
$500.00
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
1/1/2011 | published by: JZMed, Inc.
... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ...  |  read more...
$3,285.00
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
12/1/2010 | published by: GBI Research
... and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics ...  |  read more...
$3,500.00
Personalized Medicine - Opening Doors and Overcoming Challenges
11/1/2010 | published by: CBR Pharma Insights, LLC
... has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not ...  |  read more...
$3,900.00
Conference Documentation: Personalised Medicine
10/12/2010 | published by: SMI Publishing, Ltd
... latest in science, R&D, business strategies and legal issues for developing personalised therapeutics, and successfully introducing them to the marketplace. Covering various approaches towards developing personalised therapeutics - biomarkers, pharmacogenomics, pharmacogenetics and stem cells, the ...  |  read more...
$800.00
The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine
6/23/2010 | published by: Business Insights
... Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately ...  |  read more...
$3,835.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
5/1/2010 | published by: Arrowhead Publishers
... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ...  |  read more...
$2,495.00
Combination Drug/Diagnostic Products and Other Applications of Personalized Medicine-Strategic Issues Facing Companies in this Market
4/1/2010 | published by: CHI Insight Pharma Reports
... Personalized medicine has emerged as an important field for companies in both the pharmaceutical and the diagnostic industries. While many drugs in development and on the market today still follow the traditional approach where drugs ...  |  read more...
$2,995.00
Combination Drug Diagnostics: Fueling Growth of Personalized Medicine Report
4/1/2010 | published by: CHI Insight Pharma Reports
... combinations Emerging new applications Strategic options for pharmaceutical and diagnostic companies Regulatory and reimbursement issues Physician education and acceptable hurdles Interviews with experts Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine examines the role of Rx/Dx ...  |  read more...
$3,750.00
  2    
 
Our Clients